Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN proprietary product. Its product is applied to transplantation therapies and related stem-cell applications in the transplantation field. The company is also developing VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia.
| Website | https://vicapsys.com |
| Revenue | $5 million |
| Employees | 1 (0 on RocketReach) |
| Address | 7778 Mcginnis Ferry Rd 270, Suwanee, Georgia 30024, US |
| Phone | +1 972-891-8033 |
| Industry | Business Services General, Construction and Engineering, Business Services |
| Keywords | Stem Cell Applications, Regenerative Medicine, Cell-Based Therapies, Cell Therapy, Biotechnology, Tissue Engineering, Life Sciences, Pharmaceutical Research, Bioprocessing, Drug Development, Clinical Trials, Immunotherapy, Medical Technology, Biopharmaceutical, Pharmaceutical, Healthcare |
| Competitors | Deloitte, Accenture, Wipro, Capgemini, HCLTech, Cognizant Softvision, Maven Wave, an Eviden Company, Celerity It LLC, VIP CONSULTING, CAPSYS Technologies +38 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular ViCapsys , Inc. employee's phone or email?
ViCapsys , Inc. Questions
The ViCapsys , Inc. annual revenue was $5 million in 2026.
ViCapsys , Inc. is based in Suwanee, Georgia.
The NAICS codes for ViCapsys , Inc. are [54171, 541, 541714, 54, 5417].
The SIC codes for ViCapsys , Inc. are [87, 873].
